TES-Based
Immune Repertoire Analysis

Target enrichment sequencing

Target enrichment sequencing (TES) is a robust and straightforward approach to reliably sequence exomes or other regions of interest in the genome.

GeneWerk has streamlined this approach for comprehensive and cost-effective TCR and BCR analysis.

See how we can help you

TCR or BCR chain analysis

TES relies on target-specific RNA baits to capture cDNA fragments of interest. We employ bait sets optimized to account for V, J and C gene sequence homologies to enable the simultaneous capture of all TCR (α, β, γ, δ) or BCR (κ, λ, α, ε, γ, μ, δ) chains in a single reaction. Enrichment in TCR and BCR molecules is achieved through bait capture followed by deep sequencing. Our dedicated bioinformatics pipelines for immune repertoire analysis provide accurate insights into immune repertoire diversity, dynamics, and clonality.

Speak to a member or our team

Faster and more cost-effective than multiplex PCR

TES overcomes many of the disadvantages of multiplex PCR, the most widely used technology for immune repertoire analysis. In multiplex PCR, a mix of PCR primers is used for separate analysis of TCR and BCR. Due to the fixed nature of primers used, multiplex PCR cannot detect V allele variants. Moreover, due to amplification biases, multiplex PCR does not provide a true picture of the relative abundances of the different immune cell populations.

TES is currently the best-in-class approach for fast, cost-effective, and unbiased immune repertoire analysis and can be used for a w¬ide variety of applications such as minimal residual disease (MRD) detection after cancer treatment, identification of antigen-specific TCR/BCR, and monitoring of immune reconstitution.

Want to get in touch?

Consult with our experts about solutions to your biosafety challenges.

Contact us

Latest news

Read our latest press releases and announcements below.

Protagen Protein Services merges with GeneWerk

Protagen Protein Services (PPS) today announced that it will merge with GeneWerk, an Ampersand...

Read More

GeneWerk Announces Growth Equity Investment from Ampersand…

GeneWerk will expand capabilities to meet rapidly growing demand for cell and gene therapy...

Read More

Insight into Spatial and Temporal Trends of…

Genewerk GmbH in collaboration with University Heidelberg Germany provided an insight into spatial and...

Read More

GeneWerk in the Holiday Park

A little fun for everyone! This year’s company trip took us to the Holiday...

Read More
I agree to the Privacy Policy and Terms of Service.